Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
NCT00366080
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
69
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was terminated based on the interim results of a futility test.
Conditions
Narcolepsy
Interventions
DRUG:
GSK189254
Sponsor
GlaxoSmithKline